ASGCT Annual Meetings 2022-24: Travel Awards and Underrepresented Minority Travel Awards

2022-24 年 ASGCT 年会：旅行奖和代表性不足的少数族裔旅行奖

• 批准号: 10469145
• 负责人: David Barrett
• 金额: $ 1.5万
• 依托单位: AMERICAN SOCIETY OF GENE & CELL THERAPY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-05-01 至 2025-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10469145
• 关键词: American; Award; Awareness; Cell Therapy; Chronic Disease; Clinical Trials; Databases; Development; Disease; Education; Event; Funding; Future; Goals; Grant; Improve Access; Individual; Industry; Knowledge; Learning; Mission; Outcome; Population; Positioning Attribute; Postdoctoral Fellow; Public Health; Rare Diseases; Reporting; Research; Research Personnel; Running; Societies; Students; Travel; Underrepresented Minority; Underrepresented Populations; United States National Institutes of Health; career; career networking; clinical application; clinical development; cost; diversity and inclusion; experience; gene therapy; human disease; meeting abstracts; meetings; member; product development; research and development; success

American Society of Gene and Cell Therapy PA-21-151 PROJECT SUMMARY This application by The American Society of Gene and Cell Therapy (ASGCT) requests $15,000 for 10 travels award and 20 underrepresented minority travel awards ($500 per award) for students and post-doctoral fellows to attend the ASGCT Annual Meetings in 2022, 2023, and 2024—for a total of $45,000 and 90 travel awards. To determine awards, ASGCT run a report from our abstract presenter database that pools abstract applicants who are students or post-doctoral fellows. Those with the top 15 scoring abstracts receive an Excellence in Research Award (not supported by this grant), and those scoring over 3.5 receive a $500 travel award (such as those supported by this grant). Then, remaining applicants who identify as underrepresented individuals are ranked by score, and the top 20 are given travel awards (also to be supported by this grant). ASGCT abides strictly by the NIH’s definition of underrepresentation populations in selecting awardees. ASGCT’s mission is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. This project bolsters our mission by supporting early-career professional to travel to our Annual Meetings to gain exposure for their research, thereby advancing knowledge and spurning professional development that will better position those early-career professionals to make discoveries and produce clinical applications in the future.

美国基因和细胞疗法学会 PA-21-151 项目摘要 美国基因和细胞疗法学会（ASGCT）的申请要求$ 15,000 10个旅行奖和20个代表性不足的少数民族旅行奖（每张奖励500美元）的学生和 博士后研究员参加2022年，2023年和2024年的ASGCT年度会议 $ 45,000和90个旅行奖。要确定奖项，ASGCT从我们的摘要中运行报告 演示者数据库，汇集学生或博士后研究员的抽象申请人。那些 随着前15位得分摘要获得了卓越的研究奖（不支持此奖 赠款），而得分超过3.5的人将获得500美元的旅行奖（例如由此支持的奖励 授予）。然后，剩下的申请人确定为代表人数不足的人，按得分排名， 并获得了前20名旅行奖（也得到这笔赠款的支持）。 ASGCT严格遵守 NIH在选择获奖者中对人数不足的定义。 ASGCT的使命是提高知识，意识和教育，从而导致发现和教育 遗传和细胞疗法的临床应用以减轻人类疾病。这个项目灯泡 通过支持早期职业专业人员参加我们的年度会议以获取我们的任务 他们的研究接触，从而促进知识并拒绝专业发展 这将更好地定位那些早期职业专业人员，以发现并产生临床 将来的申请。